Buy & Sell Regeneron Pharmaceuticals Inc (REGN) – Regeneron Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $65.01BMarket Cap
- HealthSector
- -22.72%3M Drawdown
- $58.97BEnterprise Value
- 0.61%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 99 daysTypical Hold Time
Regeneron Pharmaceuticals Inc (REGN) is currently valued at a market capitalization of $65.01B, with an enterprise value of $58.97B. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $521 and a high of $812.27, highlighting its annual price range. Over the past three months, Regeneron Pharmaceuticals Inc has recorded a drawdown of -22.72%, reflecting recent price volatility. Regeneron Pharmaceuticals Inc offers a dividend yield of 0.61%, with the most recent dividend of $0.94 paid on 20 May 26. On average, investors hold Regeneron Pharmaceuticals Inc for approximately 99 days, indicating typical investor behavior on the platform.
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Most Recent News
Kyivstar and Ukraine's Ministry sign MOU to build sovereign AI data center boosting digital economy.
Kyivstar, part of VEON Group, signed a Memorandum of Understanding with Ukraine's Ministry of Economy to develop a sovereign AI-ready data center. This initiative aims to enhance Ukraine's digital infrastructure, secure sensitive data within the coun...

Global LIMS market to reach $5.19B by 2030, driven by automation, cloud adoption, and AI integration.
The global Laboratory Information Management Systems (LIMS) market is projected to grow from $2.88 billion in 2025 to $5.19 billion by 2030, at a CAGR of 12.5%. Growth is fueled by rising demand for laboratory automation, regulatory compliance, and d...

Global protein ingredients market to hit $121.53B by 2031, driven by demand for functional and high-protein foods.
The global protein ingredients market is projected to grow from $83.14 billion in 2026 to $121.53 billion by 2031, at a CAGR of 7.9%. Growth is fueled by rising consumer demand for functional and high-protein foods, increased awareness of protein's h...
